-
South Africa: South Africa Makes History With HIV Vaccine Trial
SA Info, 1 December 2016
South Africa is participating in an experimental vaccine programme that could prevent HIV infection. With 5 400 adults taking part, the study, called HVTN 702, is the biggest and… Read more »
-
Africa: The How, What and Why of the New HIV Vaccine Trial
The Conversation Africa, 1 November 2016
As the global quest for an HIV vaccine continues, Linda-Gail Bekker explains the significance of the latest large-scale trial underway in South Africa. Read more »
-
South Africa: Scientists Launch HIV Vaccine Trial
DW, 30 November 2016
A landmark HIV vaccine trial was launched in South Africa on the eve of World AIDS Day on December 1. Scientists hope it will help eradicate the disease. Read more »
'Holy Grail' of HIV Vaccine Trials Launched in South Africa
Professor Linda-Gail Bekker from the University of Cape Town hopes the HVTN 702 vaccine will lead to a breakthrough in combating the virus after the first results of the current trials are published by the end of 2020.
Video
-
1 December 2016
First New HIV Vaccine Efficacy Study in Seven Years Has Begun
- Publisher:
- SABC
- Publication Date:
Doctor Mookho Malahleha, co-principal investigator of HIV Vaccine Trials Network, called HVTN 702. see more »
InFocus
-
The experimental HVTN 702 vaccine, which will be the focus of a trial involving 5,400 sexually active men and women between the ages of 18 and 35, "holds great promise". Read more »
